Sierra Oncology LLC - a GSK company
Quick facts
Phase 3 pipeline
- Placebo to match danazol · Oncology
This is a placebo formulation designed to match the appearance and administration of danazol for use as a control in clinical trials. - Placebo to match ruxolitinib · Oncology
This drug is a placebo used to match the effects of ruxolitinib.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Sierra Oncology LLC - a GSK company portfolio CI brief
- Sierra Oncology LLC - a GSK company pipeline updates RSS
Frequently asked questions about Sierra Oncology LLC - a GSK company
What is Sierra Oncology LLC - a GSK company's pipeline?
Sierra Oncology LLC - a GSK company has 2 drugs in Phase 3, 0 in Phase 2, 4 in Phase 1. Late-stage candidates include Placebo to match danazol, Placebo to match ruxolitinib.
Related
- Sector hub: All tracked pharma companies